
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00845 | 4.97058823529 | 0.17 | 0.2252 | 0.165 | 27420289 | 0.19910418 | CS |
4 | -0.26155 | -59.4431818182 | 0.44 | 0.44 | 0.121 | 34565248 | 0.2016302 | CS |
12 | -0.50355 | -73.8343108504 | 0.682 | 0.7345 | 0.121 | 11781687 | 0.20286696 | CS |
26 | -0.47355 | -72.6303680982 | 0.652 | 0.89 | 0.121 | 5098970 | 0.20511367 | CS |
52 | -2.87155 | -94.1491803279 | 3.05 | 3.33 | 0.121 | 2580200 | 0.22320871 | CS |
156 | -21.02155 | -99.158254717 | 21.2 | 26.6 | 0.121 | 1027733 | 2.58519304 | CS |
260 | -95.02155 | -99.812552521 | 95.2 | 123.6 | 0.121 | 1368181 | 25.29184438 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions